A comparison of Dysport (100 U/ml) and Botox (100 U/ml) using dose conversion factor 3:1 and 1.7:1 in the treatment of cervical dystonia.

Trial Profile

A comparison of Dysport (100 U/ml) and Botox (100 U/ml) using dose conversion factor 3:1 and 1.7:1 in the treatment of cervical dystonia.

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 11 Sep 2015

At a glance

  • Drugs Botulinum toxin A (Primary)
  • Indications Torticollis
  • Focus Therapeutic Use
  • Acronyms DysBot
  • Most Recent Events

    • 11 Sep 2015 Results published in the Clinical Neuropharmacology.
    • 12 Jul 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top